Article Details
Retrieved on: 2021-08-31 21:10:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
As part of the NIH-sponsored ACTIV-2 clinical trial for COVID-19 outpatients, preliminary data revealed that a new combination monoclonal antibody treatment ...
Article found on: news.unchealthcare.org
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here